Dr. Alessandro
Calarco

Alessandro Calarco graduated in Medicine and Surgery from the Università Cattolica del Sacro Cuore in Rome in July 2007, with full marks. At the same university he completed his specialisation in Urology (April 2013, full marks) and a PhD in Urological Oncology (March 2018). He has been a Fellow of the European Board of Urology (FEBU) since 2012, and in 2018 he obtained the Advanced Clinical Training Certificate of the Endourological Society.

After working as a urologist at Cristo Re Hospital in Rome (2014–2023) and heading the Urology Unit at Clinica Villa Pia (2023–2024), since June 2024 he has directed the Unit of Robotic and Minimally Invasive Urology at San Carlo di Nancy Hospital (GVM Care & Research). He also operates at Casa di Cura Nostra Signora della Mercede and sees patients at the Viale Aventino 38 practice in Rome. A physician since 2008, he has personally performed more than 3,000 complex surgical procedures.

He is the author of 53 scientific publications (source: ORCID profile, October 2026), H-index 10 (source: PubMed), and sits on the Editorial Board of Urologia Journal and Frontiers in Surgery. He is a member of the EAU, SIU and UROP. He described the ZANCLE technique for bladder neck obstruction and the Active Guidewire technique for ureteral stones. He is the inventor of the 'Flow rate reducer for percutaneous nephrolithotripsy', patented in Italy (patent no. 102020000020944) and in several other countries (international application WO/2022/049527).